APA (7th ed.) Citation

LM, S., A, P., T, G., A, P., JM, A., N, L., . . . ID, M. (2026). Polypharmacology of S-1117, an Fc-fused IgG-selective degrading enzyme, for chronic treatment of autoantibody-mediated diseases. Proceedings of the National Academy of Sciences of the United States of America, 123(13), e2518366123. https://doi.org/10.1073/pnas.2518366123

Chicago Style (17th ed.) Citation

LM, Sanmarco, et al. "Polypharmacology of S-1117, an Fc-fused IgG-selective Degrading Enzyme, for Chronic Treatment of Autoantibody-mediated Diseases." Proceedings of the National Academy of Sciences of the United States of America 123, no. 13 (2026): e2518366123. https://doi.org/10.1073/pnas.2518366123.

MLA (9th ed.) Citation

LM, Sanmarco, et al. "Polypharmacology of S-1117, an Fc-fused IgG-selective Degrading Enzyme, for Chronic Treatment of Autoantibody-mediated Diseases." Proceedings of the National Academy of Sciences of the United States of America, vol. 123, no. 13, 2026, p. e2518366123, https://doi.org/10.1073/pnas.2518366123.